Hyperlipidemia: A risk factor for chronic allograft dysfunction

Kidney International, Supplement

Volumn 61, Issue 80, 2002, Pages

  Beneyto, Isabel Castello ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Graft loss; Hypertriglyceridemia; Lipid profile; Renal transplantation

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; APOLIPOPROTEIN B; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LIPOPROTEIN A; LISINOPRIL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PRAVASTATIN; RAPAMYCIN; STATIN; TACROLIMUS; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CHOLESTEROL;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFECT; GLOMERULOSCLEROSIS; GRAFT SURVIVAL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MULTIVARIATE ANALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN RESTRICTION; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; BLOOD; CHRONIC DISEASE; POSTOPERATIVE COMPLICATION; REVIEW;

CHOLESTEROL; CHRONIC DISEASE; HUMANS; HYPERLIPIDEMIAS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TRIGLYCERIDES;

EID: 0036097083     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Hyperlipidemia: A risk factor for chronic allograft dysfunction
2. Pathogenesis and treatment perspectives of chronic graft rejection
3. Chronic transplant rejection
4. Current thinking on chronic renal allograft rejection: Issues, concerns and recommendations from a 1997 roundtable discussion
5. The Banff 97 working classification of renal allograft pathology
6. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors
7. Histopathologic findings associated with a chronic, progressive decline in renal allograft function
8. Chronic rejection and suboptimal immunosuppression
9. The hyperfiltration hypothesis in human renal transplantation
10. Hypertension is associated with hyperlipidemia, coronary heart disease and chronic graft failure in kidney transplant patients
11. Pretransplant hypertension: A major risk factor for chronic progressive renal dysfunction?
12. Atherosclerosis and lipid disorders after renal transplantation
13. The influence of pretransplant lipid abnormalities on early results of renal transplantation
14. Rôle des lipides dans le rejet chronique
15. Persistent hyperlipidemia in renal transplant recipients
16. Lipid abnormalities in cyclosporine-prednisolone treated renal transplant recipients
17. Relation of cyclosporine blood levels to adverse effects on lipoproteins
18. Impact of dyslipemia in renal transplant recipients
19. Apolipoproteins and immunohistological differentiation of cells in the arterial wall of kidneys in transplant arteriopathy. Morphological parallels with atherosclerosis
20. Interaction of the allogenic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts
21. Immunosuppression enhances atherogenicity of lipid profile after transplantation
22. Presence of oxidized LDL in transplant arteriosclerotic lesions obtained from renal transplant recipients
23. Lipid metabolism and oxidative stress in renal transplantation: Implications for chronic rejection
24. Hyperlipidemia and progressive renal disease
25. Pathogenesis and treatment perspectives of chronic graft rejection
26. Metabolic factors and outcome of organ transplantation
27. Increased lipoproteins and fibrinogen in chronic renal allograft dysfunction
28. Chronic vascular rejection and hyperlipoproteinemia in renal transplant patients
29. Hyperlipidemia in renal transplantation: Risk factor for long term renal outcome
30. Hypercholesterolemia is associated with increased kidney graft loss caused by chronic rejection in male patients with previous acute rejection
31. Cholesterol as an independent predictor of outcome after renal transplantation
32. Protocol allograft biopsies at the design of clinical trials aimed to prevent or treat chronic allograft nephropaty
33. Risk factors predicting chronic rejection of renal allografts
34. Clinical correlation between allograft failure and hyperlipidemia
35. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors
36. Effect of early hyperlipidemia on graft and patient survival in cyclosporine-treated renal transplant patients
37. No clinical evidence of hyperlipidemia as a risk factor for chronic renal allograft failure
38. Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years
39. Thirty year trends in clinical kidney transplantation
40. Dietary protein and the rennin-angiotensin system in chronic renal allograft rejection
41. The effects of lisinopril on renal function in proteinuric renal transplant recipients
42. The effects of lipids on graft outcome
43. Impact of pravastatin on outcomes after cardiac transplantation